Kuldeep Singh RajputFounder

United States - Boston, Massachusetts

Kuldeep Singh Rajput is the CEO and Founder of OutcomesAI, a healthcare technology company focused on building trusted artificial medical intelligence to supercharge healthcare teams. Nursing shortage and clinical capacity are leading problems in healthcare, OutcomesAI is addressing this crisis by building a multi-modal AI optimized for healthcare applications – with an initial focus on assisting care teams with AI Companions.

Prior to OutcomesAI, Kuldeep was the Founder and CEO of Biofourmis, a global technology enabled care delivery company that brings the right care to any person anywhere! Biofourmis’ innovative solutions provide people everywhere with connected access to hospital-level services, virtual provider networks for remote care, in-home services, and life-changing clinical trials—all without leaving their homes.

Recognized as the “Forbes 30 Under 30”, Kuldeep has demonstrated strong leadership experience with building teams, developing talents, and successfully growing, and managing strategic partnerships with global pharmaceutical manufacturers, health systems and Payers. He uses his background and experience in biomedical engineering and data from the Massachusetts Institute of Technology (MIT) to unfold his vision of “Predicting and Preventing Serious Medical Events using AI”. During his Ph.D. studies at the National University of Singapore (NUS), he built bioelectronic implants, which aim to control biological processes and treat diseases by modulating electric impulses.

He believes in giving back and is part of the Milken Institute Young Leaders Circle (YLC), supporting the mission of providing people access to education and healthcare for stable economic growth. Kuldeep has been featured in major publications and has been a keynote speaker at numerous prestigious conferences like TED.

Specialties: Entrepreneur, Fund Raising, Building Companies, Generative AI, Digital Therapeutics, Licensing, and Deal Structure, Healthcare Strategy, Digital Healthcare, Wearable Biosensors, Pharmaceuticals